BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel


NEWSLETTERS
FREENewsletters
Archive

NEWS
News bySubject
News byDisease
News byDate
PLoS
SearchNews

CAREER NETWORK
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

DIVERSITY

HOTBEDS
Regional News
BiotechBay™
BiotechBeach™
Genetown™
PharmCountry™
BioCapital™
BioMidwest™
BioNC™
BioForest™
SouthernPharm™
BioCanadaEast™
US Device™

INVESTOR
Market Summary
News
IPOs

PROFILES
CompanyProfiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event

RESOURCES
RealEstate
Business Opportunities
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Pharmos Corporation (OP: PARS)
0.0370 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 10:08 AM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,000
Open 0.0370
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0370
Today's Range 0.0370 - 0.0370
52wk Range 0.0200 - 0.0900
Shares Outstanding 60,170,671
Dividend Yield N/A
Top News
More News
Pharmos Corporation Reports Second Quarter 2012 Results
July 30, 2012
Company Continues to seek a partner for Levotofisopam for the Treatment of Gout Read More
from PR Newswire
Pharmos Corporation Announces Successful Completion Of Proof-of-concept Clinical Trial Of Levotofisopam For The Treatment Of Gout
May 17, 2012
RAPID AND SIGNIFICANT REDUCTION IN URIC ACID OBSERVED IN ALL SUBJECTS Read More
from PR Newswire

More News
Read More
Pharmos Corporation Reports First Quarter 2012 Results
April 16, 2012
from PR Newswire
Pharmos Provides Update on Ongoing Clinical Trial of Levotofisopam for the Treatment of Gout
April 05, 2012
from PR Newswire
Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results
February 17, 2012
from PR Newswire
Pharmos Announces Dosing of First Patients in Clinical Trial of Levotofisopam for the Treatment of Gout
January 10, 2012
from PR Newswire
Pharmos Corporation Reports 2011 Third Quarter Results
October 31, 2011
from PR Newswire
Pharmos Corporation Reports 2011 Second Quarter Results
August 08, 2011
from PR Newswire
Pharmos Corporation Reports First Quarter 2011 Results
April 28, 2011
from PR Newswire
Pharmos Corporation Reports Fourth Quarter and Full Year 2010 Results
February 17, 2011
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
About BioSpace | Contact Us | Privacy Statement | Terms of Use
Post Your News | Post Event | Post Jobs | Post Company Profile | Advertising Opportunities

RSS FEED All News | Breaking News | Featured Stories

© 2007 BioSpace, Inc - an onTargetjobs company
Visit other onTargetjobs companies
Niche Job Boards | Biotechnology Jobs | Healthcare Jobs | Nursing Jobs | Accounting Jobs | Hospitality Jobs
Hospitality Jobs Canada | Hospitality Jobs UK